BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36377544)

  • 1. Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo.
    Kambale-Kombi P; Djang'eing'a RM; Alworong'a Opara JP; Minon JM; Sepulchre E; Bours V; Floch A; Pirenne F; Tshilumba CK; Batina-Agasa S
    Transfus Med; 2023 Apr; 33(2):137-146. PubMed ID: 36377544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study.
    Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA
    Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
    Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
    Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo.
    Kambale-Kombi P; Marini Djang'eing'a R; Alworong'a Opara JP; Minon JM; Boemer F; Bours V; Tonen-Wolyec S; Kayembe Tshilumba C; Batina-Agasa S
    Hematology; 2021 Dec; 26(1):199-205. PubMed ID: 33594960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre.
    Regalado-Artamendi I; Pérez-Corral AM; García-Morín M; Cela E; Beléndez C; Bardón-Cancho EJ; Pérez-Rus G; Pérez-Sánchez I; Pascual C; Monsalvo S; Falero C; Díez-Martín JL; Anguita J
    Blood Transfus; 2021 Jul; 19(4):292-299. PubMed ID: 33085598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Students' knowledge on sickle cell disease in Kisangani, Democratic Republic of the Congo.
    Kambale-Kombi P; Marini Djang'eing'a R; Alworong'a Opara JP; Tonen-Wolyec S; Kayembe Tshilumba C; Batina-Agasa S
    Hematology; 2020 Dec; 25(1):91-94. PubMed ID: 32070266
    [No Abstract]   [Full Text] [Related]  

  • 7. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA polymorphisms and risk of red blood cell alloimmunisation in polytransfused patients with sickle cell anaemia.
    Rodrigues C; Sell AM; Guelsin GAS; Higa TT; Pagliarini E Silva S; Macedo LC; Sippert EÂ; de Alencar JB; Zanette Â; Acorsi CRL; Castilho L; Visentainer JEL
    Transfus Med; 2017 Dec; 27(6):437-443. PubMed ID: 28881103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloimmunisation rates of sickle cell disease patients in the United States differ from those in other geographical regions.
    Zheng Y; Maitta RW
    Transfus Med; 2016 Jun; 26(3):225-30. PubMed ID: 27197689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity of sickle cell trait and albinism: a cross-sectional survey in the Democratic Republic of the Congo.
    Kambale-Kombi P; Djang'eing'a RM; Alworong'a Opara JP; Wa Inena GI; Falay Sadiki D; Boemer F; Bours V; Tshilumba CK; Batina-Agasa S
    Pan Afr Med J; 2020; 35():127. PubMed ID: 32637025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.
    Shih AW; Yan MTS; Elahie AL; Barty RL; Liu Y; Berardi P; Azzam M; Siddiqui R; Parvizian MK; Mcdougall T; Heddle NM; Al-Habsi KS; Goldman M; Cote J; Athale U; Verhovsek MM
    Transfus Med; 2020 Aug; 30(4):263-274. PubMed ID: 32432400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries.
    Pirenne F; Floch A; Diop S
    Lancet Haematol; 2023 Jun; 10(6):e468-e476. PubMed ID: 37060916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Red Blood Cell Alloimmunization Among Pediatric Patients With Sickle Cell Disease in Saudi Arabia.
    Al-Asmari B; Baothman A; Almohammadi M; Aljuaid M; Jastaniah W
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):e284-e289. PubMed ID: 38857199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy?
    Agasa B; Bosunga K; Opara A; Tshilumba K; Dupont E; Vertongen F; Cotton F; Gulbis B
    Transfus Med; 2010 Feb; 20(1):62-5. PubMed ID: 19712051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
    Jariwala K; Mishra K; Ghosh K
    Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Rankin A; Darbari D; Campbell A; Webb J; Mo YD; Jacquot C; Delaney M; Luban NLC; Nickel RS
    Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R; Hendrickson JE
    Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The erythrocyte alloimmunisation in patients with sickle cell anaemia: a systematic review.
    da Cunha Gomes EG; Machado LAF; de Oliveira LC; Neto JFN
    Transfus Med; 2019 Jun; 29(3):149-161. PubMed ID: 29845661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.